The One-stop Guide to Oligo Modification
Link Technologies Ltd, a specialist oligonucleotide reagent manufacturer, has dedicated a section of its new, freely available 2013/14 Product Guide to ‘Modification Strategies in Oligonucleotide Synthesis’.
Increasingly, modified oligos are playing an important role across a broad range of life science and clinical-based research groups and, for example, show significant promise as agents to optimise drug delivery. In the new Product Guide, Link Technologies has compiled a comprehensive resource for scientists working with modified oligonucleotides, including educational references, detailed product information, established protocols and application notes, for assured oligo synthesis and use. This go-to guide for oligonucleotide chemistry can be downloaded for free from www.linktech.co.uk
ISO 9001:2008 certified, Link Technologies offers an extensive range of modified phosphoramidites, enabling scientists to take advantage of numerous techniques and a diverse range of applications. This includes brancher phosphoramidites to facilitate the generation of branched oligos as a tool for gene expression analysis or gene correction, and hydrophobic group modifiers (cholesterol, tocopherol and palmitate) which have had recent success in aiding the cellular delivery of oligonucleotides. Application-orientated for easy use, the 2013/14 Product Guide directs scientists to the most suitable products for purpose and, with the associated tried-and-tested protocols, allows users to have confidence in the performance of their modified oligos.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance